How are KRYS collar max profit and max loss calculated?

Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the KRYS collar priced from the end-of-day chain at a 30-day expiry (ATM IV 40.10%), the computed maximum profit is $2,216.00 per contract and the computed maximum loss is -$1,784.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a KRYS collar?

The breakeven for the KRYS collar priced on this page is roughly $367.84 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current KRYS market-implied 1-standard-deviation expected move is approximately 11.50%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current KRYS implied volatility affect this collar?

KRYS ATM IV is at 40.10% with IV rank near 16.14%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

KRYS Collar Strategy

KRYS (Krystal Biotech, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Krystal Biotech, Inc. is a clinical-stage biotechnology company focused on developing redosable gene therapies to address severe orphan diseases across the United States. Its most advanced therapeutic candidate, beremagene geperpavec (B-VEC), is currently undergoing Phase III clinical evaluation for the treatment of dystrophic epidermolysis bullosa. The company's pipeline also includes several other promising programs: KB105 is in Phase I/II clinical trials for patients suffering from deficient autosomal recessive congenital ichthyosis; KB301 is also in Phase I/II development, aiming to ameliorate wrinkles and other signs of aging or damaged skin. Additionally, Krystal Biotech is conducting preclinical research on KB407 for cystic fibrosis and KB104 for Netherton syndrome. In its earlier discovery phase, the company is exploring candidates such as KB5xx for chronic skin conditions and multiple KB3xx programs targeting aesthetic dermatological concerns. Krystal Biotech, Inc. was established in 2015 and is based in Pittsburgh, Pennsylvania.

KRYS (Krystal Biotech, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $10.97B, a trailing P/E of 48.45, a beta of 0.53 versus the broader market, a 52-week range of 130.5-376.28, average daily share volume of 299K, a public-listing history dating back to 2017, approximately 275 full-time employees. These structural characteristics shape how KRYS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.53 indicates KRYS has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. The trailing P/E of 48.45 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple.

What is a collar on KRYS?

A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.

Current KRYS snapshot

As of June 30, 2026, spot at $369.29, ATM IV 40.10%, IV rank 16.14%, expected move 11.50%. The collar on KRYS below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.

Why this collar structure on KRYS specifically: IV regime affects collar pricing on both sides; compressed KRYS IV at 40.10% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 11.50% (roughly $42.45 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated KRYS expiries trade a higher absolute premium for lower per-day decay. Position sizing on KRYS should anchor to the underlying notional of $369.29 per share and to the trader's directional view on KRYS stock.

KRYS collar setup

The KRYS collar below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With KRYS near $369.29, the first option leg uses a $390.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed KRYS chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 KRYS shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 100 shares	Stock	$369.29	long
Sell 1	Call	$390.00	$5.95
Buy 1	Put	$350.00	$4.50

KRYS collar risk and reward

Net Premium / Debit: -$36,784.00
Max Profit (per contract): $2,216.00
Max Loss (per contract): -$1,784.00
Breakeven(s): $367.84
Risk / Reward Ratio: 1.242

Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.

KRYS collar payoff curve

Modeled P&L at expiration across a range of underlying prices for the collar on KRYS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	-$1,784.00
$81.66	-77.9%	-$1,784.00
$163.31	-55.8%	-$1,784.00
$244.96	-33.7%	-$1,784.00
$326.61	-11.6%	-$1,784.00
$408.26	+10.6%	+$2,216.00
$489.92	+32.7%	+$2,216.00
$571.57	+54.8%	+$2,216.00
$653.22	+76.9%	+$2,216.00
$734.87	+99.0%	+$2,216.00

When traders use collar on KRYS

Collars on KRYS hedge an existing long KRYS stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.

KRYS thesis for this collar

The market-implied 1-standard-deviation range for KRYS extends from approximately $326.84 on the downside to $411.74 on the upside. A KRYS collar hedges an existing long KRYS position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current KRYS IV rank near 16.14% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on KRYS at 40.10%. As a Healthcare name, KRYS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to KRYS-specific events.

KRYS collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. KRYS positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move KRYS alongside the broader basket even when KRYS-specific fundamentals are unchanged. Always rebuild the position from current KRYS chain quotes before placing a trade.

Frequently asked questions

What is a collar on KRYS?: A collar on KRYS is the collar strategy applied to KRYS (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With KRYS stock trading near $369.29, the strikes shown on this page are snapped to the nearest listed KRYS chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are KRYS collar max profit and max loss calculated?: Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the KRYS collar priced from the end-of-day chain at a 30-day expiry (ATM IV 40.10%), the computed maximum profit is $2,216.00 per contract and the computed maximum loss is -$1,784.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a KRYS collar?: The breakeven for the KRYS collar priced on this page is roughly $367.84 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current KRYS market-implied 1-standard-deviation expected move is approximately 11.50%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a collar on KRYS?: Collars on KRYS hedge an existing long KRYS stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
How does current KRYS implied volatility affect this collar?: KRYS ATM IV is at 40.10% with IV rank near 16.14%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.